Hybridoma Clone 299-2 HRPII 4A5 Producing Monoclonal Antibody to Pfalciparum Histidine Rich Protein 2 or Monoclonal Antibody Purified from same Hybridoma

Case ID:
C10644

C10644: Monoclonal antibody to histidine rich protein 2 specific to Plasmodium falciparum (Hybridoma clone 299-2 HRPII 4A5)


Value Proposition:

• This technology has an application to address a major patient need.
• The ability to reliably diagnose malaria infections.
• The monoclonal antibodies specific to histidine rich protein 2.

Technical Details:

Malaria is severe disease and caused by a parasite called Plasmodium. According to the World Health Organization, there were 247 million malaria cases and nearly a million deaths in 2006. Key intervention to control malaria is prompt and effective treatment with first step of good and reliable diagnostic testing. Hybridoma clone 299-2 HRPII 4A5 producing the monoclonal antibodies that are specific to an abundant malaria protein called histidine rich protein 2 specific to Plasmodium falciparum.

Looking for Partners:

The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite.



Publications/Associated Cases:

Lee N, et al (2006) Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol. 44(8): 2773-2778.

Patent Information:
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum